A1AT3_HORSE
ID A1AT3_HORSE Reviewed; 52 AA.
AC P38030;
DT 01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-1994, sequence version 1.
DT 02-JUN-2021, entry version 77.
DE RecName: Full=Alpha-1-antiproteinase 3;
DE AltName: Full=Alpha-1-antitrypsin 3;
DE AltName: Full=Alpha-1-proteinase inhibitor 3;
DE AltName: Full=SPI3;
DE Flags: Fragments;
OS Equus caballus (Horse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
OX NCBI_TaxID=9796;
RN [1]
RP PROTEIN SEQUENCE.
RC TISSUE=Plasma;
RX PubMed=1772402; DOI=10.1007/bf02399689;
RA Patterson S.D., Bell K., Shaw D.C.;
RT "The equine major plasma serpin multigene family: partial characterization
RT including sequence of the reactive-site regions.";
RL Biochem. Genet. 29:477-499(1991).
RN [2]
RP STRUCTURE OF CARBOHYDRATES.
RX PubMed=2111994;
RA Patterson S.D., Bell K.;
RT "The carbohydrate side chains of the major plasma serpins of horse and
RT wallaby: analyses of enzymatic and chemically treated (including 'Smith
RT degradation') protein blots by lectin binding.";
RL Biochem. Int. 20:429-436(1990).
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- TISSUE SPECIFICITY: Plasma.
CC -!- DOMAIN: The reactive center loop (RCL) extends out from the body of the
CC protein and directs binding to the target protease. The protease
CC cleaves the serpin at the reactive site within the RCL, establishing a
CC covalent linkage between the serpin reactive site and the active site
CC of the protease. The resulting inactive serpin-protease complex is
CC highly stable (By similarity). {ECO:0000250}.
CC -!- PTM: N-glycosylated; contains glycans with bi- and triantennary side
CC chains.
CC -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR PIR; C61219; C61219.
DR MEROPS; I04.974; -.
DR PeptideAtlas; P38030; -.
DR Proteomes; UP000002281; Unplaced.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
PE 1: Evidence at protein level;
KW Acute phase; Direct protein sequencing; Glycoprotein; Protease inhibitor;
KW Reference proteome; Secreted; Serine protease inhibitor.
FT CHAIN 1..>52
FT /note="Alpha-1-antiproteinase 3"
FT /id="PRO_0000094093"
FT REGION 1..20
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT SITE 23..24
FT /note="Reactive bond"
FT NON_CONS 22..23
FT /evidence="ECO:0000305"
FT NON_TER 52
SQ SEQUENCE 52 AA; 5923 MW; B5E0A35119BE53D0 CRC64;
EDLQGDAVPE EXATKDDNEH PQTLLLTNVE FNXRPFVLII YDRNTKSPLF VG